rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-4-24
|
pubmed:abstractText |
HMG-CoA reductase inhibitors play several roles in the maintenance of organ transplants. We investigated the role of pitavastatin, a potent and newly developed HMG-CoA reductase inhibitor, in cardiac allograft rejection and mechanism of graft arterial disease (GAD) suppression.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1093-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17452900-Acute Disease,
pubmed-meshheading:17452900-Animals,
pubmed-meshheading:17452900-Cell Proliferation,
pubmed-meshheading:17452900-Cholesterol,
pubmed-meshheading:17452900-Chronic Disease,
pubmed-meshheading:17452900-Cytokines,
pubmed-meshheading:17452900-Gene Expression Regulation,
pubmed-meshheading:17452900-Graft Rejection,
pubmed-meshheading:17452900-Graft Survival,
pubmed-meshheading:17452900-Heart Transplantation,
pubmed-meshheading:17452900-Immunosuppressive Agents,
pubmed-meshheading:17452900-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:17452900-Male,
pubmed-meshheading:17452900-Mice,
pubmed-meshheading:17452900-Myocytes, Smooth Muscle,
pubmed-meshheading:17452900-Quinolines,
pubmed-meshheading:17452900-Spleen,
pubmed-meshheading:17452900-Survival Rate,
pubmed-meshheading:17452900-Transplantation, Homologous,
pubmed-meshheading:17452900-Triglycerides
|
pubmed:year |
2007
|
pubmed:articleTitle |
Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan. jsuzuki.cvm@tmd.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|